Ex-Celgene Corporation, Sanofi-Aventis (New Jersey) Drug Execs Admit Roles in Stock Scheme

Published: Oct 09, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A former executive of Summit-based Celgene pharmaceuticals and another man have pleaded guilty to running an insider trading scheme. John Lazorchak was director of financial reporting at Celgene Corp., a biotech drugmaker. He and five other people were charged last November with participating in a five-year-long insider trading scheme.

Help employers find you! Check out all the jobs and post your resume.

Back to news